Myocarditis Following a Third BNT162b2 Vaccination Dose in Military Recruits in Israel.

Friedensohn, Limor; Levin, Dan; Fadlon-Derai, Maggie; Gershovitz, Liron; Fink, Noam; Glassberg, Elon; Gordon, Barak

Friedensohn, Limor; Levin, Dan; Fadlon-Derai, Maggie; Gershovitz, Liron; Fink, Noam; Glassberg, Elon; Gordon, Barak.

Friedensohn L; Medical Corps, Israel Defense Forces, Israel.
Levin D; Medical Corps, Israel Defense Forces, Israel.
Fadlon-Derai M; Medical Corps, Israel Defense Forces, Israel.
Gershovitz L; Medical Corps, Israel Defense Forces, Israel.
Fink N; Medical Corps, Israel Defense Forces, Israel.
Glassberg E; Medical Corps, Israel Defense Forces, Israel.
Gordon B; Medical Corps, Israel Defense Forces, Israel.

JAMA ; 327(16): 1611-1612, 2022 04 26.

Article in English | MEDLINE | ID: covidwho-1838095

Subject(s)

BNT162 Vaccine; Military Personnel; Myocarditis; Vaccination; BNT162 Vaccine/administration & dosage; BNT162 Vaccine/adverse effects; Humans; Israel/epidemiology; Military Personnel/statistics & numerical data; Myocarditis/epidemiology; Myocarditis/etiology; Vaccination/adverse effects; Vaccination/statistics & numerical data

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Vaccination / BNT162 Vaccine / Military Personnel / Myocarditis Type of study: Observational study Topics: Vaccines Limits: Humans Country/Region as subject: Asia Language: English Journal: JAMA Year: 2022 Document Type: Article Affiliation country: Jama.2022.4425

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google